Form 4: Axon Enterprise Director Sells 1,000 Shares Under 10b5-1 Trading Plan

Michael Garnreiter, a director at Axon Enterprise, sold 1,000 shares of common stock at $599.53 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Michael Garnreiter, a director of Axon Enterprise, Inc., sold 1,000 shares of the company's common stock on November 15, 2024.
• The sale was executed at a price of $599.53 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted by Mr. Garnreiter on May 17, 2024.
• Following the sale, Mr. Garnreiter directly owns 25,259 shares of Axon Enterprise common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to a pre-planned stock sale by a director. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend or issue within the industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The use of a 10b5-1 trading plan is a common method for insiders to sell shares without concerns about insider trading violations.
• The sale of 1,000 shares by a director is not unusual and does not indicate any significant deviation from industry norms.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but it is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

Keywords

Axon Enterprise, insider trading, Form 4, stock sale, Rule 10b5-1, Michael Garnreiter, director